Biopharma/Biotech Analyst Chen and Biotech Analysts Schmidt, Schimmer & Watsek, along with Dr. Sabari of NYU Langone Health System discuss which antibody drug conjugates are changing the treatment paradigm in oncology (relevant companies: PFE SGEN AMAM MRK JNJ LLY IMGN BCYC VINC MRSN ZYME) on an Analyst/Industry conference call to be held on November 17 at 11 am. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PFE:
- Serina Therapeutics announces POZ polymer license agreement with Pfizer
- Astellas Pharma, Pfizer announce FDA approval of Xtandi sNDA
- Cantor biotech/biopharma analysts hold analyst/industry conference call
- Pfizer (NYSE:PFE) to Layoff 500 Workers at UK Site
- Pfizer to cut 500 jobs, discontinue PSSM operations in Kent, Sky News reports
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue